Oncology
Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at helping patients with neuroendocrine tumors.
Rare Diseases
Ipsen continues to develop innovative medicines in rare diseases to address conditions with unmet needs, with specific investment in pituitary pathologies and growth disorders.
Neuroscience
Our focus on movement disorders includes improving the mobility, autonomy and quality of life of patients with these very disabling motor disorders. Our involvement in developing neurotoxins dates back over two decades.
Products
Discover the products that Ipsen Canada currently offers.
Last update 01/08/2018